Invex Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2019 - 2020
Period Ending	Sep '25 Sep 22, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2019 - 2020
Market Capitalization	12	7	5	15	37	47	Upgrade
Market Cap Growth	97.53%	48.33%	-70.00%	-59.60%	-21.43%	-46.04%	Upgrade
Enterprise Value	7	1	-2	-10	6	14	Upgrade
Last Close Price	0.16	0.09	0.06	0.05	0.13	0.16	Upgrade
PS Ratio	52.49	29.20	3.72	32.74	204.12	-	Upgrade
PB Ratio	2.29	1.27	0.79	0.71	1.31	1.48	Upgrade
P/TBV Ratio	2.29	1.27	0.79	0.71	1.31	1.48	Upgrade
EV/Sales Ratio	29.03	3.85	-	-	32.02	-	Upgrade
Asset Turnover	0.04	0.04	0.08	0.02	0.01	-	Upgrade
Quick Ratio	24.79	24.79	14.18	14.50	29.36	49.71	Upgrade
Current Ratio	24.79	24.79	14.18	14.50	29.36	49.71	Upgrade
Return on Equity (ROE)	-8.72%	-8.72%	-12.20%	-31.18%	-13.05%	-8.09%	Upgrade
Return on Assets (ROA)	-7.65%	-7.65%	-9.22%	-20.43%	-8.10%	-5.16%	Upgrade
Return on Capital (ROIC)	-8.11%	-8.11%	-9.91%	-21.49%	-8.32%	-5.41%	Upgrade
Earnings Yield	-3.97%	-7.13%	-36.41%	-51.56%	-10.63%	-4.82%	Upgrade
Buyback Yield / Dilution	-0.51%	-0.51%	-0.19%	-0.02%	-0.03%	-33.77%	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.